跳至主要内容
临床试验/NCT04146883
NCT04146883Unknown不适用

Post-procedure Antibiotic Prophylaxis for Cardiac Electrical Device Implantation: ABxFREE Study

National Cheng-Kung University Hospital1 个研究点 分布在 1 个国家目标入组 800 人开始时间: 2019年8月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
800
试验地点
1
主要终点
Cardiac implantable electronic device related infection

研究概览

简要总结

This study is a multi-center open-label randomized study, and we sought to investigate the redundancy of post-procedural prophylactic antibiotics in cardiac implantable electronic device implantation. There are 2 arms in this study. One arm will receive pre-procedural intravenous antibiotics only. The other arm will receive both pre-procedural intravenous antibiotics and post-procedural 3-day oral antibiotics.

详细描述

There is general agreement on the benefits of preoperative prophylactic antibiotics which had been documented in previous studies. Concerns of bacterial resistance and unnecessary cost, our prospective observational case-control study had suggested the redundancy of post-procedural antibiotics. In this well-designed study, we sought to investigate the efficacy of post-procedural antibiotics and confirm the hypothesis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Eligible for permanent pacemaker or implantable cardioverter defibrillator implantation according to current guidelines

排除标准

  • Hospitalization for more than 7 days
  • End stage renal disease with hemodialysis or peritonealysis
  • Patients receive cardiac resynchronization therapy, His-bundle pacemaker, leadless pacemaker, or sub-cutaneous implantable cardioverter defibrillator

研究组 & 干预措施

Post procedural antibiotics treatment

Experimental

This group was treated with pre-procedural (pacemaker or ICD implantation) prophylactic once intravenous antibiotics (cefazolin 1000mg or else if allergy to cefazolin) and post procedural oral prophylactic antibiotics

干预措施: Antibiotics (Drug)

结局指标

主要结局

Cardiac implantable electronic device related infection

时间窗: 1 year

Any local and systemic signs/symptoms (pocket erosion, localized pocket erythema, swelling, heatness, pain, fever, bacteremia, lead/valvular vegetation) will be monitored during follow-up. The definition and classification of CIED related infection are based on the current guideline and expert consensus statement.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ju-Yi Chen

Associate Professor, Department of Internal Medicine, College of Medicine, National Cheng Kung University

National Cheng-Kung University Hospital

研究点 (1)

Loading locations...

相似试验